Related references
Note: Only part of the references are listed.Next Generation Strategies for Geroprotection via mTORC1 Inhibition
Sabrina N. Dumas et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging
Candice E. Van Skike et al.
AGING CELL (2020)
Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment
Ellen Quarles et al.
AGING CELL (2020)
Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation
Xiang Chen et al.
AGING-US (2020)
Bring Back the Rat!
Christy S. Carter et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
The mTOR pathway is necessary for survival of mice with short telomeres
Iole Ferrara-Romeo et al.
NATURE COMMUNICATIONS (2020)
Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape
Lonneke V. Nouwen et al.
CELLS (2020)
Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells
Edy Y. Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Rapamycin and Alzheimer's disease: Time for a clinical trial?
Matt Kaeberlein et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Rapamycin and Alzheimer disease: a double-edged sword?
Julian M. Carosi et al.
AUTOPHAGY (2019)
Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice
Yohei Kawakami et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg/Th17 in a mouse model
Zhenfei Li et al.
NEUROSCIENCE LETTERS (2019)
Rapamycin for longevity: opinion article
Mikhail V. Blagosklonny
AGING-US (2019)
Melatonin and Rapamycin Attenuate Isoflurane-Induced Cognitive Impairment Through Inhibition of Neuroinflammation by Suppressing the mTOR Signaling in the Hippocampus of Aged Mice
Hui Yuan et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets
Aubrey M. Sills et al.
AMERICAN JOURNAL OF PRIMATOLOGY (2019)
Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial
Christina Lee Chung et al.
GEROSCIENCE (2019)
Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR)
Julia P. Snyder et al.
FRONTIERS IN IMMUNOLOGY (2019)
mTOR drives cerebral blood flow and memory deficits in LDLR-/- mice modeling atherosclerosis and vascular cognitive impairment
Jordan B. Jahrling et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment
Candice E. Van Skike et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice
Peter C. Reifsnyder et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Long term rapamycin treatment improves mitochondrial DNA quality in aging mice
Jason Bielas et al.
EXPERIMENTAL GERONTOLOGY (2018)
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
Ellen Kraig et al.
EXPERIMENTAL GERONTOLOGY (2018)
Repeated Systemic Treatment with Rapamycin Affects Behavior and Amygdala Protein Expression in Rats
Martin Hadamitzky et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Effects of rapamycin on growth hormone receptor knockout mice
Yimin Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TORC1 inhibition enhances immune function and reduces infections in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson's Disease
Debora Masini et al.
FRONTIERS IN NEUROLOGY (2018)
Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain
Rebecca L. Cox et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Antonella Tramutola et al.
TRANSLATIONAL NEURODEGENERATION (2018)
mTOR pathway activation drives lung cell senescence and emphysema
Amal Houssaini et al.
JCI INSIGHT (2018)
Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways
Lisa A. Lesniewski et al.
AGING CELL (2017)
Rapamycin Protects Sepsis-Induced Cognitive Impairment in Mouse Hippocampus by Enhancing Autophagy
Wenyu Liu et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)
Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
Stephanie E. Siegmund et al.
HUMAN MOLECULAR GENETICS (2017)
MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells
Russell G. Jones et al.
IMMUNITY (2017)
NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model
Nancy L. Nadon et al.
EBIOMEDICINE (2017)
A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
Silvan R. Urfer et al.
GEROSCIENCE (2017)
Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism
Rong Wang et al.
AGING CELL (2017)
Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes
Kavithalakshmi Sataranatarajan et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an -glucosidase inhibitor or a Nrf2-inducer
Randy Strong et al.
AGING CELL (2016)
Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island
Sebastian I. Arriola Apelo et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
Activation of mTOR signaling leads to orthopedic surgery-induced cognitive decline in mice through β-amyloid accumulation and tau phosphorylation
Wenzhen Shen et al.
MOLECULAR MEDICINE REPORTS (2016)
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
Alessandro Bitto et al.
ELIFE (2016)
Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β Pathway
Wei Zhang et al.
PARKINSONS DISEASE (2016)
Traumatic Brain Injury Stimulates Neural Stem Cell Proliferation via Mammalian Target of Rapamycin Signaling Pathway Activation
Xiaoting Wang et al.
ENEURO (2016)
Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice
Vincent Hurez et al.
AGING CELL (2015)
Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)
Corinna Ross et al.
AGING-US (2015)
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
Arlan Richardson et al.
EXPERIMENTAL GERONTOLOGY (2015)
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nicolas Herranz et al.
NATURE CELL BIOLOGY (2015)
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Remi-Martin Laberge et al.
NATURE CELL BIOLOGY (2015)
Acute Sirolimus Overdose: A Multicenter Case Series
Alessandro Ceschi et al.
PLOS ONE (2015)
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
Simon C. Johnson et al.
FRONTIERS IN GENETICS (2015)
Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms
Emily L. Goldberg et al.
AGING CELL (2015)
The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy
Robert Siman et al.
PLOS ONE (2015)
Regulation of innate immune cell function by mTOR
Thomas Weichhart et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy
Xiang Bai et al.
PATHOBIOLOGY OF AGING AND AGE-RELATED DISEASES (2015)
Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart
Dao-Fu Dai et al.
AGING CELL (2014)
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
Richard A. Miller et al.
AGING CELL (2014)
BMAL1-dependent regulation of the mTOR signaling pathway delays aging
Rohini V. Khapre et al.
AGING-US (2014)
Acute systemic rapamycin induces neurobehavioral alterations in rats
Martin Hadamitzky et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
Irina G. Popovich et al.
CANCER BIOLOGY & THERAPY (2014)
eRapa Restores a Normal Life Span in a FAP Mouse Model
Paul Hasty et al.
CANCER PREVENTION RESEARCH (2014)
Longevity, aging and rapamycin
Dan Ehninger et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Immune Memory-Boosting Dose of Rapamycin Impairs Macrophage Vesicle Acidification and Curtails Glycolysis in Effector CD8 Cells, Impairing Defense against Acute Infections
Emily L. Goldberg et al.
JOURNAL OF IMMUNOLOGY (2014)
Rapamycin Extends Life and Health in C57BL/6 Mice
Yiqiang Zhang et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease
Teng Jiang et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
Wilson C. Fok et al.
PLOS ONE (2014)
mTOR inhibition improves immune function in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Strategies for the management of adverse events associated with mTOR inhibitors
Bruce Kaplan et al.
TRANSPLANTATION REVIEWS (2014)
Reduced mammalian target of rapamycin activity facilitates mitochondrial retrograde signaling and increases life span in normal human fibroblasts
Chad Lerner et al.
AGING CELL (2013)
Late-life rapamycin treatment reverses age-related heart dysfunction
James M. Flynn et al.
AGING CELL (2013)
Rapamycin extends life span of Rb1+/- mice by inhibiting neuroendocrine tumors
Carolina B. Livi et al.
AGING-US (2013)
Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Rapamycin extends murine lifespan but has limited effects on aging
Frauke Neff et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tamara Tchkonia et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus
Rachael Keating et al.
NATURE IMMUNOLOGY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
mTOR Inhibition Ameliorates Cognitive and Affective Deficits Caused by Disc1 Knockdown in Adult-Born Dentate Granule Neurons
Miou Zhou et al.
NEURON (2013)
Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex
Marco Cambiaghi et al.
NEUROPHARMACOLOGY (2013)
Rapamycin Reverses Status Epilepticus-Induced Memory Deficits and Dendritic Damage
Amy L. Brewster et al.
PLOS ONE (2013)
Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
Sefika Ozcelik et al.
PLOS ONE (2013)
Inhibition of IGF-1R Prevents Ionizing Radiation-Induced Primary Endothelial Cell Senescence
Ronald Allan M. Panganiban et al.
PLOS ONE (2013)
Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease
Ines Moreno-Gonzalez et al.
NATURE COMMUNICATIONS (2013)
Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1ß and enhancing NMDA signaling
Smita Majumder et al.
AGING CELL (2012)
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice
Elena A. Komarova et al.
AGING-US (2012)
New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesis
Maria Comas et al.
AGING-US (2012)
Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil in PIK3CA mutant gastric cancer cells
Bhaskar Bhattacharya et al.
CANCER BIOLOGY & THERAPY (2012)
Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases
Osama Hussein et al.
CANCER LETTERS (2012)
Suppression of replicative senescence by rapamycin in rodent embryonic cells
Tatiana V. Pospelova et al.
CELL CYCLE (2012)
mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
Ramiro Iglesias-Bartolome et al.
CELL STEM CELL (2012)
Randomized Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stents vs. Sirolimus-Eluting Stents for Percutaneous Coronary Intervention in Chronic Total Occlusion - CAtholic Total Occlusion Study (CATOS) Trial -
Hun-Jun Park et al.
CIRCULATION JOURNAL (2012)
Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence
Cecilia A. Hinojosa et al.
EXPERIMENTAL GERONTOLOGY (2012)
Rapamycin impairs UV induction of mutant-p53 overexpressing cell clusters without affecting tumor onset
P. Voskamp et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Inhibition of Mammalian Target of Rapamycin Augments Lipopolysaccharide-Induced Lung Injury and Apoptosis
Jill A. Fielhaber et al.
JOURNAL OF IMMUNOLOGY (2012)
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
Peter T. Tsai et al.
NATURE (2012)
SIRT1 is required for the effects of rapamycin on high glucose-inducing mesangial cells senescence
Sifang Zhang et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2012)
CHRONIC INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN BY RAPAMYCIN MODULATES COGNITIVE AND NON-COGNITIVE COMPONENTS OF BEHAVIOR THROUGHOUT LIFESPAN IN MICE
J. Halloran et al.
NEUROSCIENCE (2012)
Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
Fresnida J. Ramos et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis
Xiaojie Zhang et al.
AUTOPHAGY (2011)
Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells
Toshiaki Ohara et al.
CANCER SCIENCE (2011)
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation
Talita M. Marin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo Synergism with Chemotherapy
Mir Alireza Hoda et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Richard A. Miller et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
Smita Majumder et al.
PLOS ONE (2011)
Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
Olga V. Leontieva et al.
PLOS ONE (2011)
Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage
Loredana Stoica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells
Kan Cao et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Are we ready to move away from nature? The rapamycin story
Monica Mita et al.
TARGETED ONCOLOGY (2011)
Common toxicities of mammalian target of rapamycin inhibitors
Scott A. Soefje et al.
TARGETED ONCOLOGY (2011)
The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas
Sushma Vemulapalli et al.
TARGETED ONCOLOGY (2011)
Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma
Donna E. Hansel et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
Vladimir N. Anisimov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Rapamycin Inhibits Anal Carcinogenesis in Two Preclinical Animal Models
Marie K. Stelzer et al.
CANCER PREVENTION RESEARCH (2010)
Why Women Have More Alzheimer's Disease Than Men: Gender and Mitochondrial Toxicity of Amyloid-beta Peptide
Jose Vina et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer's disease
Ewa Kloskowska et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Cutting Edge: Rapamycin Augments Pathogen-Specific but Not Graft-Reactive CD8+ T Cell Responses
Ivana R. Ferrer et al.
JOURNAL OF IMMUNOLOGY (2010)
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APCMin/+ mice
G. E. Koehl et al.
ONCOGENE (2010)
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease
Patricia Spilman et al.
PLOS ONE (2010)
Participation of Mammalian Target of Rapamycin Complex 1 in Toll-Like Receptor 2-and 4-Induced Neutrophil Activation and Acute Lung Injury
Emmanuel Lorne et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor
L. Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Rapamycin decelerates cellular senescence
Zoya N. Demidenko et al.
CELL CYCLE (2009)
Targeting mTOR globally in cancer Thinking beyond rapamycin
Boris Shor et al.
CELL CYCLE (2009)
mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging
Rogerio M. Castilho et al.
CELL STEM CELL (2009)
Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
Jozef Hanes et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Beneficial Effects of Mammalian Target of Rapamycin Inhibition on Left Ventricular Remodeling After Myocardial Infarction
Sebastian J. Buss et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
David E. Harrison et al.
NATURE (2009)
Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells
Chinnaswamy Jagannath et al.
NATURE MEDICINE (2009)
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
Emma Puighermanal et al.
NATURE NEUROSCIENCE (2009)
Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging
Li Zhuo et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2009)
mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
Chong Chen et al.
SCIENCE SIGNALING (2009)
Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia
Marc A. Mueller et al.
ATHEROSCLEROSIS (2008)
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart et al.
IMMUNITY (2008)
MTOR: The mammalian target of replication
Ezra E. W. Cohen
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sirolimus-induced vascular dysfunction -: Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation
Alexander Jabs et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Diabetes after transplantation and sirolimus: What's the connection?
Martha Pavlakis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis
Matthew A. King et al.
MOLECULAR PHARMACOLOGY (2008)
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
Dan Ehninger et al.
NATURE MEDICINE (2008)
Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice
Teruaki Fujishita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
Eva Hernando et al.
NATURE MEDICINE (2007)
Sirolimus-eluting coronary stents: a review
Alexandre Abizaid
VASCULAR HEALTH AND RISK MANAGEMENT (2007)
Impaired endothelial vasomotor function after sirolimus-eluting stent implantation
Soichiro Fuke et al.
CIRCULATION JOURNAL (2007)
Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation
Toshio Imanishi et al.
ATHEROSCLEROSIS (2006)
Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis
Xiao-Ming Gao et al.
JOURNAL OF HYPERTENSION (2006)
Rapamycin alleviates toxicity of different aggregate-prone proteins
Z Berger et al.
HUMAN MOLECULAR GENETICS (2006)
Extension of chronological life span in yeast by decreased TOR pathway signaling
RW Powers et al.
GENES & DEVELOPMENT (2006)
Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients
M Kaeberlein et al.
SCIENCE (2005)
Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload
TZ Ha et al.
CARDIOVASCULAR RESEARCH (2005)
Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice - Inhibitory effect on monocyte chemotaxis
R Pakala et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Senescence and immortalization: role of telomeres and telomerase
JW Shay et al.
CARCINOGENESIS (2005)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo
MO Boluyt et al.
CARDIOVASCULAR DRUGS AND THERAPY (2004)
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload
JR McMullen et al.
CIRCULATION (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
P Kapahi et al.
CURRENT BIOLOGY (2004)
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients
JD Morrisett et al.
JOURNAL OF LIPID RESEARCH (2002)
Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition
C Geula et al.
ACTA NEUROPATHOLOGICA (2002)
Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers
C Brattström et al.
THERAPEUTIC DRUG MONITORING (2000)
Share Paper
